Severe Maternal Morbidity and Risk of Mortality Beyond the Postpartum Period

• Published in: Obstetrics and gynecology (New York. 1953) Vol. 137; no. 2; pp. 277 - 284
• Main Authors: Ukah, U Vivian, Dayan, Natalie, Potter, Brian J, Ayoub, Aimina, Auger, Nathalie
• Format: Journal Article
• Language: English
• Published: United States 01.02.2021
• Subjects: Adult; Female; Humans; Longitudinal Studies; Pregnancy; Pregnancy Complications - mortality; Quebec - epidemiology; Time Factors; Young Adult; Quebec
• ISSN: 0029-7844; 1873-233X
• DOI: 10.1097/AOG.0000000000004223

To examine long-term risks of mortality after a pregnancy complicated by severe maternal morbidity. We analyzed a longitudinal cohort of 1,229,306 women who delivered in the province of Quebec, Canada from 1989 through 2016. Severe maternal morbidity included conditions such as cerebrovascular accidents, acute renal failure, severe preeclampsia, and other life-threatening complications. The outcome was in-hospital mortality after the last pregnancy, categorized as postpartum (42 days or fewer after delivery) and long-term (43 days to 29 years after delivery). We estimated hazard ratios (HRs) ofr mortality with 95% CI for severe maternal morbidity compared with no severe morbidity, using Cox regression models adjusted for maternal characteristics. Severe maternal morbidity occurred in 2.9% of women. The mortality rate associated with severe maternal morbidity was 0.86 per 1,000 person-years compared with 0.41 per 1,000 person-years for no morbidity. Compared with no morbidity, severe maternal morbidity was associated with two times the rate of death any time after delivery (95% CI 1.81-2.20). Severe cardiac complications (HR 7.00, 85% CI 4.94-9.91), acute renal failure (HR 4.35, 95% CI 2.66-7.10), and cerebrovascular accidents (HR 4.03, 95% CI 2.17-7.48) were the leading morbidities associated with mortality after 42 days. Women who experience severe maternal morbidity have an accelerated risk of mortality beyond the postpartum period compared with women who do not experience severe morbidity. More intensive clinical follow-up may be merited for women with serious pregnancy complications.